Page last updated: 2024-11-05

vesnarinone and Acute Disease

vesnarinone has been researched along with Acute Disease in 2 studies

Acute Disease: Disease having a short and relatively severe course.

Research Excerpts

ExcerptRelevanceReference
"Vesnarinone (VES) has been used for treatment of patients with congestive heart failure."1.29Effects of vesnarinone, a novel orally active inotropic agent with an immunosuppressive action, on experimental cardiac transplantation in rats. ( DiSesa, VJ; Fyfe, BS; Goldstein, C; Mohiuddin, M; Momeni, R; Shen, Z; Whitman, GJ; Yokoyama, H, 1996)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Teerlink, JR1
Metra, M1
ZacĂ , V1
Sabbah, HN1
Cotter, G1
Gheorghiade, M1
Cas, LD1
Yokoyama, H1
Momeni, R1
Goldstein, C1
Mohiuddin, M1
Shen, Z1
Fyfe, BS1
Whitman, GJ1
DiSesa, VJ1

Reviews

1 review available for vesnarinone and Acute Disease

ArticleYear
Agents with inotropic properties for the management of acute heart failure syndromes. Traditional agents and beyond.
    Heart failure reviews, 2009, Volume: 14, Issue:4

    Topics: Acute Disease; Cardiotonic Agents; Digoxin; Dobutamine; Etiocholanolone; Exercise Test; Heart Failur

2009

Other Studies

1 other study available for vesnarinone and Acute Disease

ArticleYear
Effects of vesnarinone, a novel orally active inotropic agent with an immunosuppressive action, on experimental cardiac transplantation in rats.
    Transplantation, 1996, Dec-15, Volume: 62, Issue:11

    Topics: Acute Disease; Animals; Cardiotonic Agents; Chronic Disease; Graft Rejection; Heart Transplantation;

1996